- Home
- BLRX vs FTEL Comparison
BLRX vs FTEL Comparison
Compare BLRX & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- FTEL
- Stock Information
- Founded
- BLRX 2003
- FTEL 2007
- Country
- BLRX Israel
- FTEL Australia
- Employees
- BLRX N/A
- FTEL N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- FTEL
- Sector
- BLRX Health Care
- FTEL
- Exchange
- BLRX Nasdaq
- FTEL Nasdaq
- Market Cap
- BLRX 12.1M
- FTEL 11.1M
- IPO Year
- BLRX 2011
- FTEL 2023
- Fundamental
- Price
- BLRX $5.74
- FTEL $0.47
- Analyst Decision
- BLRX Strong Buy
- FTEL
- Analyst Count
- BLRX 2
- FTEL 0
- Target Price
- BLRX $19.00
- FTEL N/A
- AVG Volume (30 Days)
- BLRX 2.0M
- FTEL 102.9K
- Earning Date
- BLRX 05-27-2025
- FTEL 06-17-2025
- Dividend Yield
- BLRX N/A
- FTEL N/A
- EPS Growth
- BLRX N/A
- FTEL N/A
- EPS
- BLRX N/A
- FTEL N/A
- Revenue
- BLRX $22,340,000.00
- FTEL $4,990,695.00
- Revenue This Year
- BLRX N/A
- FTEL N/A
- Revenue Next Year
- BLRX N/A
- FTEL N/A
- P/E Ratio
- BLRX N/A
- FTEL N/A
- Revenue Growth
- BLRX 91.68
- FTEL 29.02
- 52 Week Low
- BLRX $2.30
- FTEL $0.40
- 52 Week High
- BLRX $35.60
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- BLRX 73.10
- FTEL 36.64
- Support Level
- BLRX $3.88
- FTEL $0.40
- Resistance Level
- BLRX $7.77
- FTEL $0.50
- Average True Range (ATR)
- BLRX 0.75
- FTEL 0.05
- MACD
- BLRX 0.19
- FTEL 0.01
- Stochastic Oscillator
- BLRX 56.81
- FTEL 39.59
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.